ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660027 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660027; 2) Community: the network communities that were significantly associated with the response to NSC 660027; 3) Molecule: the relationships between components within communities and NSC 660027; 4) MDR: the compounds that were significantly associated with the NSC 660027.

NSC Compound Enrichment Correlation
NSC 761826 (Z)-3-((1-(4-fluoro-3-methoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.00415749398947839 -0.06402318
NSC 679509 Null 0.00423163567577548 0.30932099
NSC 685989 Dihydroartemisinyl ether, stereoisomer of NSC-685988 0.00423163567577548 0.046013534
NSC 716688 Null 0.00423163567577548 0.015397135
NSC 728317 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}butane Bis(trifluoroacetate) 0.00423163567577548 0.49431427
NSC 747169 Null 0.00423163567577548 0.14005006
NSC 264137 Celiptium 0.00423163567577551 0.59938679
NSC 364830 Camptothecin Derivative 0.00423163567577551 0.4337343
NSC 648114 ANTINEOPLASTIC-D648114 0.00423163567577551 0.6167647
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.00423163567577551 0.40305362
Total:52  Current:7    [First] [Prev] [Next] [Last]